. . . . . . . . . . . . "a(CHEBI:wortmannin) -> r(HGNC:TP53)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "We also demonstrate that wortmannin-dependent PI3K/Akt inhibition upregulated p53 protein levels in most AML cases, and this correlated with diminished MRP1 expression and enhanced phosphorylation of murine double minute 2 (MDM2). " . . "Selventa" . . . . "2014-07-03T14:33:08.052+02:00"^^ . . .